Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls

Area of Science:

• Hepatology
• Molecular Biology
• Virology

Background:

• The hepatitis B virus (HBV) HBx protein is crucial for viral infection and implicated in liver cancer (hepatocarcinogenesis).
• HBx activates the RAS-RAF-MAP kinase pathway, influencing transcription factors and DNA synthesis.

Purpose of the Study:

• To elucidate the molecular mechanisms by which HBx protein influences cell cycle progression and contributes to viral carcinogenesis.
• To investigate HBx's role in regulating cell cycle checkpoints and its interaction with signaling pathways.

Main Methods:

• Studied the effect of HBx on cell cycle progression from quiescence (G0) to S phase.
• Assessed the activation of cyclin-dependent kinases (CDKs) CDK2 and CDC2 with their associated cyclins (E, A, B).
• Investigated the role of RAS activation and serum dependence in HBx-mediated cell cycle stimulation.

Main Results:

• HBx significantly shortens the time for cells to enter S phase and accelerates transit through G0/G1 and G2/M checkpoints.
• HBx enhances the activation and association of CDK2/cyclin E/A and CDC2/cyclin B, overriding serum dependence.
• While both HBx and serum require RAS activation, only HBx shortens checkpoint intervals, suggesting an additional effector pathway.

Conclusions:

• HBx protein stimulates cell proliferation by activating RAS and an unknown effector, potentially linked to JUN activation or p53 interaction.
• By deregulating cell cycle checkpoints, HBx promotes genetic instability, increasing the likelihood of accumulating mutations that drive carcinogenesis.
• These findings provide a molecular basis for HBx's role in HBV-associated liver cancer development.